Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
UCB Pharma
This study is for subjects who have been diagnosed with migraine for at least one year and who are currently taking an effective abortive medication(s).
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
History of migraines headaches for 1 year and well documented 3 month retrospective history of migraines.
Experience 2-8 migraines per month but not more than 15 headache days per month. There should be at least 48 hours of freedom between headaches.
On effective stable abortive medication(s) for the acute treatment of migraine.
You may not be if
Subject in another investigational drug or device study within the last 30 days or is currently in another investigational drug trial.
Use of triptans or ergots for migraine abortive treatment \> 2-3 days per calendar week 2 months prior to screening.
Experience 15 or more headache days per month of any kind 2 months prior to screening.
Has another consistent or chronic form of headache.
Unable to stop medications, herbs, vitamins, or minerals used to prevent a migraine from occurring.
Pregnant or nursing women and those of child bearing potential who are not surgically sterile, or 2 years post menopausal, or do not practice 2 combined methods of birth control, unless sexually abstinent, during the trial.
Significant laboratory or electrocardiograms (ECG) abnormalities
Significant medical history including cardiovascular abnormalities.
